PP69. AN AUDIT OF MYELOSUPPRESSION IN PATIENTS WITH GLIOBLASTOMA RECEIVING SIX WEEKS RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY AT THE CHRISTIE | Zendy

AI Assistant Blog Pricing

PP69. AN AUDIT OF MYELOSUPPRESSION IN PATIENTS WITH GLIOBLASTOMA RECEIVING SIX WEEKS RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE CHEMOTHERAPY AT THE CHRISTIE

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.